Literature DB >> 23985533

The importance of Raf dimerization in cell signaling.

Alyson K Freeman1, Daniel A Ritt1, Deborah K Morrison1.   

Abstract

The Raf family of protein kinases are key signaling intermediates, acting as a central link between the membrane-bound Ras GTPases and the downstream kinases MEK and ERK. Raf kinase regulation is well-known for its complexity but only recently has it been realized that many of the mechanisms involved in Raf regulation also modulate Raf dimerization, now acknowledged to be a required step for Raf signaling in multiple cellular contexts. Recent studies have shown that Raf dimerization is necessary for normal Ras-dependent Raf kinase activation and contributes to the pathogenic function of disease-associated mutant Raf proteins with all but high intrinsic kinase activity. Raf dimerization has also been found to alter therapeutic responses and disease progression in patients treated with ATP-competitive Raf inhibitors as well as certain other kinase-targeted drugs. This demonstration of clinical significance has stimulated the recent development of biosensor assays that can monitor inhibitor-induced Raf dimerization as well as studies demonstrating the therapeutic potential of blocking Raf dimerization.

Entities:  

Keywords:  B-Raf; C-Raf; ERK cascade; MEK; Raf family kinases; Ras

Mesh:

Substances:

Year:  2013        PMID: 23985533      PMCID: PMC3976976          DOI: 10.4161/sgtp.26117

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  26 in total

Review 1.  Isotype-specific functions of Raf kinases.

Authors:  C Hagemann; U R Rapp
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

2.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

Review 3.  The RAF proteins take centre stage.

Authors:  Claudia Wellbrock; Maria Karasarides; Richard Marais
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

4.  Regulation of Raf-1 by direct feedback phosphorylation.

Authors:  Michele K Dougherty; Jürgen Müller; Daniel A Ritt; Ming Zhou; Xiao Zhen Zhou; Terry D Copeland; Thomas P Conrads; Timothy D Veenstra; Kun Ping Lu; Deborah K Morrison
Journal:  Mol Cell       Date:  2005-01-21       Impact factor: 17.970

5.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.

Authors:  Mathew J Garnett; Sareena Rana; Hugh Paterson; David Barford; Richard Marais
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

6.  Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization.

Authors:  M A Farrar; J Alberol-Ila; R M Perlmutter
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

7.  Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.

Authors:  Z Luo; G Tzivion; P J Belshaw; D Vavvas; M Marshall; J Avruch
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

8.  Regulation and role of Raf-1/B-Raf heterodimerization.

Authors:  Linda K Rushworth; Alison D Hindley; Eric O'Neill; Walter Kolch
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization.

Authors:  Hugo Lavoie; Neroshan Thevakumaran; Gwenaëlle Gavory; John J Li; Abbas Padeganeh; Sébastien Guiral; Jean Duchaine; Daniel Y L Mao; Michel Bouvier; Frank Sicheri; Marc Therrien
Journal:  Nat Chem Biol       Date:  2013-05-19       Impact factor: 15.040

View more
  39 in total

Review 1.  RAS Proteins and Their Regulators in Human Disease.

Authors:  Dhirendra K Simanshu; Dwight V Nissley; Frank McCormick
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

2.  Analyses of the oncogenic BRAFD594G variant reveal a kinase-independent function of BRAF in activating MAPK signaling.

Authors:  Nicholas J Cope; Borna Novak; Zhiwei Liu; Maria Cavallo; Amber Y Gunderwala; Matthew Connolly; Zhihong Wang
Journal:  J Biol Chem       Date:  2020-01-12       Impact factor: 5.157

3.  Chemotherapeutic drug selectivity between wild-type and mutant BRaf kinases in colon cancer.

Authors:  Jianchun Zhang; Tao Ji
Journal:  J Mol Model       Date:  2016-12-05       Impact factor: 1.810

4.  Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit.

Authors:  Daniel A Ritt; María T Abreu-Blanco; Lakshman Bindu; David E Durrant; Ming Zhou; Suzanne I Specht; Andrew G Stephen; Matthew Holderfield; Deborah K Morrison
Journal:  Mol Cell       Date:  2016-11-23       Impact factor: 17.970

Review 5.  KSR as a therapeutic target for Ras-dependent cancers.

Authors:  Beth K Neilsen; Danielle E Frodyma; Robert E Lewis; Kurt W Fisher
Journal:  Expert Opin Ther Targets       Date:  2017-04-07       Impact factor: 6.902

Review 6.  KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer.

Authors:  Andrew M Waters; Channing J Der
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

7.  GTP-Dependent K-Ras Dimerization.

Authors:  Serena Muratcioglu; Tanmay S Chavan; Benjamin C Freed; Hyunbum Jang; Lyuba Khavrutskii; R Natasha Freed; Marzena A Dyba; Karen Stefanisko; Sergey G Tarasov; Attila Gursoy; Ozlem Keskin; Nadya I Tarasova; Vadim Gaponenko; Ruth Nussinov
Journal:  Structure       Date:  2015-06-04       Impact factor: 5.006

Review 8.  Ras-Mediated Activation of the Raf Family Kinases.

Authors:  Elizabeth M Terrell; Deborah K Morrison
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

Review 9.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

Review 10.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.